Kombi-Kalz

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Kombi-Kalz

Property Description
Active ingredient Calcium Carbonate, Cholecalciferol (Vitamin D3)
Form Chewable tablets, Film-coated tablets, Granules for oral solution
Pharmacological class Minerals and Electrolytes, Vitamin D Supplement, Combination Drug
General Purpose Prevention and treatment of calcium and Vitamin D deficiencies
Origin Derived (Mineral Salt and Vitamin Analog)

Defining Kombi-Kalz: A Combination Mineral and Vitamin Supplement

Kombi-Kalz is a combination drug classified within the therapeutic groups of Minerals and Electrolytes and Vitamin D Supplements. It is an oral pharmaceutical product specifically formulated to counteract co-existing deficiencies of both calcium and Vitamin D, which are necessary for maintaining the body's mineral homeostasis. This synergistic formulation delivers a direct mineral source alongside a biological regulator, distinguishing it from single-agent therapies. Kombi-Kalz is commonly utilized for patient groups, such as postmenopausal women or individuals with dietary restrictions, who require reliable supplementation. The product is derived from a mineral salt and a synthetic or derived vitamin analog, intended for administration via the oral route.

What Active Ingredients Are in Kombi-Kalz?

The core composition of Kombi-Kalz consists of two functional active ingredients: Calcium Carbonate and a specific Vitamin D analog, typically Cholecalciferol (Vitamin D3). Calcium Carbonate serves as the primary source of elemental calcium, the mineral essential for bone health. The Cholecalciferol component is included because it is metabolically required to enhance the intestinal absorption of calcium. Calcium and cholecalciferol are clinically recognized for their positive effects on calcium homeostasis and bone mineralisation. This means the combination helps the body take in and use the vital minerals efficiently. This drug is supplied in several dosage forms, including chewable tablets, film-coated tablets, and granules for oral solution, offering flexibility in how the patient takes the required supplements.

General Purpose: Why is This Combination Important?

The general therapeutic purpose of Kombi-Kalz is to sustain skeletal strength and support overall metabolic function where concurrent deficiencies exist. The formulation’s dual action ensures that the body not only receives the necessary mineral but also possesses the regulatory mechanism—the enhanced calcium absorption—to properly utilize the mineral. This combined approach is clinically recognized for the management of states where an individual does not absorb enough calcium or vitamin D from their diet. This emphasizes that the supplement is designed to correct common nutritional imbalances that impact bone health and overall metabolism.

Advertisements

What side effects are possible with Kombi-Kalz?

Possible side effects and safety information

Official regulatory documents classify the potential side effects of calcium carbonate and cholecalciferol combination products into specific frequency and System-Organ Classes (SOC). The primary safety focus centers on the risk of systemic mineral imbalance.

Metabolic and Gastrointestinal Side Effects

Adverse reactions involving the Metabolism and Nutrition Disorders are generally classified as Uncommon, meaning they may affect up to 1 in 100 people. These include Hypercalcaemia (elevated calcium levels in the blood) and Hypercalciuria (elevated calcium excretion in the urine).

Reactions involving the Gastrointestinal Disorders are classified as Rare, potentially affecting up to 1 in 1,000 people. These effects include constipation, flatulence, nausea, abdominal pain, and diarrhoea. Skin reactions such as rash, pruritus (itching), and urticaria (hives) are also documented as Rare.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions documented in regulatory documents include severe Hypersensitivity reactions, such as angio-oedema. Overdose may lead to severe hypercalcaemia with risks including renal damage, and the rare occurrence of Milk-alkali syndrome.

Safety restrictions mandate that the supplement is Contraindicated in individuals with pre-existing Hypercalcaemia, Hypercalciuria, or severe renal impairment. For patients on long-term treatment or with certain pre-existing conditions like sarcoidosis, the official labeling requires monitoring of plasma calcium, urinary calcium, and renal function. The risk of hypercalcaemia is also noted to increase when used concurrently with specific medications, such as thiazide diuretics.

Advertisements

Overdose and Emergency Response

Overdose: Overdose and when to seek help

Official regulatory information for Kombi-Kalz (Calcium Carbonate / Colecalciferol) overdose strictly addresses the consequences of hypercalcemia (excessive calcium in the blood) resulting from overexposure.

Overdose scope

Feature Official Regulatory Statements
Documented Manifestations Early symptoms include anorexia, nausea, vomiting, fatigue, headache, and confusion. Later manifestations may include excessive thirst (polydipsia) and frequent urination (polyuria).
Physiological Systems Affected Primary systems affected are the Renal System (kidneys), Cardiovascular System (heart), and Central Nervous System (CNS).
Severe Outcomes Documented serious outcomes include renal failure, the development of cardiac arrhythmias, and neurological deterioration such as coma or stupor due to severe hypercalcemia.
Population-Specific Notes Patients with pre-existing renal impairment or granulomatous diseases (e.g., sarcoidosis) are noted to be at a higher risk for severe complications.

Required Emergency Response

The official instruction is to discontinue the product immediately upon suspicion of overdose. Urgent medical attention is required, and emergency services must be contacted when the individual exhibits signs of severe toxicity or life-threatening manifestations, including collapse, seizures, or significant trouble breathing. Management in a medical setting focuses on aggressive IV hydration and the use of calcium-lowering agents to counteract the effects of hypercalcemia, which defines the acute toxic state.

Advertisements

Therapeutic Uses of Kombi-Kalz

What Kombi-Kalz Treats: Main Uses and Benefits


The primary therapeutic domain for this combination supplement is the management of symptoms related to systemic imbalance caused by concurrent deficiencies of calcium and Vitamin D. This supplement is commonly used across conditions characterized by periods of heightened symptoms related to low bone mineral density.

Kombi-Kalz is generally considered relevant for the treatment and prevention of Hypocalcemia and Hypovitaminosis D, and is generally considered relevant as a nutritional component to specific osteoporosis therapy. This usage is commonly used in clinical settings where patients face a heightened risk of developing these deficiencies, such as those with gastrointestinal malabsorption disorders or those with persistently limited sun exposure. The supplement may be part of symptomatic management relevant to bone weakness, and contributes to easing the overall symptom load related to musculoskeletal manifestations.

“It is commonly used across domains where additional symptomatic support is needed to maintain functional stability, especially in managing symptoms linked to long-term mineral deficits.”

The therapy also is applied in addressing symptoms related to physical discomfort and helps with managing symptoms of increased muscular activity that result from systemic imbalance. It supports the patient during difficult episodes by easing the distress of muscle weakness and involuntary cramps or spasms. This approach supports general well-being during symptomatic phases.


Quick Fact: Relief for Musculoskeletal Symptoms
Kombi-Kalz assists with maintaining functional stability by supporting the normal function of nerves and muscles, helping to ease the overall symptom burden caused by deficiency.
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Kombi-Kalz?

The eligibility for Kombi-Kalz (Calcium Carbonate and Cholecalciferol) is strictly defined by regulatory authorities to ensure safe use, primarily based on a patient’s current mineral status and organ function.

Absolute Contraindications (Must Not Use)

Condition Reason for Non-Eligibility
Hypercalcaemia High calcium levels in the blood from any cause.
Severe Renal Impairment Severe kidney failure (cannot metabolize Vitamin D properly).
Hypervitaminosis D Documented Vitamin D overdosage.
Nephrolithiasis / Nephrocalcinosis History of kidney stones or renal calcification.

Conditional Eligibility and Restrictions

Adults and the Elderly are the generally approved populations. Use in the paediatric population (children and adolescents) is officially not recommended.

Pregnancy and Lactation: Use is permitted only to correct a documented combined calcium and vitamin D deficiency and must be medically supervised.

Organ/Disease Restrictions: Patients with mild to moderate renal impairment or sarcoidosis are eligible, but require careful medical supervision and mandatory periodic monitoring of serum and urinary calcium levels to prevent potential complications.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions with Kombi-Kalz primarily involve two documented mechanisms: reduced gastrointestinal absorption of co-administered medicines and an increased risk of hypercalcemia that can worsen the effect of other drugs.

Documented Interactions Requiring Dosing Separation

The calcium component can bind to certain medicines in the gut, reducing their efficacy. To mitigate this effect, official regulatory documents stipulate a required time separation between administration of Kombi-Kalz and the following drug categories:

  • Tetracycline and Fluoroquinolone Antibiotics (e.g., Ciprofloxacin, Doxycycline): A separation of at least 2 hours before or 4-6 hours after Kombi-Kalz is typically required.
  • Bisphosphonates and Levothyroxine (thyroid hormones): Administration must be separated, generally by at least 4 hours for Levothyroxine, to ensure proper absorption.
  • The absorption of the Vitamin D component may be reduced by ion exchange resins (e.g., Cholestyramine) and Orlistat.

Documented Interactions Requiring Monitoring

Other documented interactions require close medical supervision and/or laboratory testing due to the potential for altered calcium levels:

  • Cardiac Glycosides (e.g., Digoxin): The combination increases the risk of serious cardiac rhythm disturbances (arrhythmias) due to hypercalcemia, necessitating routine monitoring of ECG and serum calcium levels.
  • Thiazide Diuretics (e.g., Hydrochlorothiazide): These diuretics decrease calcium excretion, increasing the risk of hypercalcemia and requiring routine monitoring of serum and urinary calcium levels.
  • Glucocorticoids (corticosteroids) can reduce the absorption of calcium, which may require monitoring of TSH and calcium levels, depending on the patient's condition.
Advertisements

Mechanism of Action

Regulation of Intestinal Calcium Transport and Substrate Provision

This mechanism involves the dual action of Calcium Carbonate providing the essential mineral substrate ( Ca^2+) and Cholecalciferol (Vitamin D3) serving as the key biological regulator. The active form of Cholecalciferol binds to Vitamin D Receptors (VDR), triggering the synthesis of transport proteins like TRPV6 and Calbindin-D9k that actively draw the Ca^2+ ions across the intestinal wall. This synergy increases the efficiency of absorption, resulting in a net positive systemic Ca^2+ influx**.

Modulation of Systemic Calcium Homeostasis

The absorbed Ca^2+ is channeled to support two critical physiological processes: it supplies the primary component for the ongoing maintenance of skeletal structural integrity and acts as a feedback signal in the endocrine system. The resulting adequate plasma Ca^2+ concentration suppresses the secretion of Parathyroid Hormone (PTH) from the parathyroid gland. This stabilizing effect on the PTH axis contributes to the tight regulation of Ca^2+ levels required for neuromuscular excitability and skeletal structural integrity.

Advertisements

Dosage and Administration Information

How Kombi-Kalz is Used: Administration Guidelines

This section details the instructions for using the combination supplement Kombi-Kalz (Calcium Carbonate and Cholecalciferol).


Administration and Dosing

Kombi-Kalz is intended exclusively for the oral route of administration. The specific method of intake depends on the dosage form:

  • Chewable tablets must be chewed or sucked completely, not swallowed whole, to ensure proper release of the active ingredients.
  • Granules for oral solution must be fully dissolved in water prior to consumption.

Standard Dosage and Frequency

Patient Group Indication (Label-based) Typical Dosing Regimen Frequency
Adults & Elderly Deficiency Treatment / Osteoporosis Adjunct One dose (e.g., 500 mg Ca/400 IU D3 strength) Twice Daily

The supplement is generally taken on a daily basis for sustained periods, aligning with its use in managing chronic nutritional imbalances.

Contextual Use Instructions

To optimize absorption, it is often recommended to take Kombi-Kalz with food or after meals. For patients on a twice-daily regimen, the doses should be appropriately spaced throughout the day.

Separation from Other Medicines: To prevent drug-drug interactions, Kombi-Kalz must be taken separately (e.g., by at least 2 to 4 hours) from certain other medications, such as specific antibiotics (tetracyclines/quinolones) and thyroid hormone treatments (levothyroxine).

Special Population Constraint: The medicine is not for use in patients with severe renal impairment.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Kombi-Kalz


Evidence for Use in Nutritional Supplementation and Vitamin Status

Research has explored Kombi-Kalz use in populations with Vitamin D and Calcium status concerns. Studies monitoring this area include randomized controlled trials (RCTs), which are often considered a high-standard type of research, alongside observational studies. The research examined outcomes related to systemic or functional imbalance by monitoring changes in the levels of Vitamin D and calcium circulating in the blood.

Studies reported measurements where increases in Vitamin D levels were observed during the study period. Trials also reported how serum calcium and phosphorus levels evolved in the observed populations. Research highlights changes measured during the study period, but it is important to understand that these study results reflect the specific conditions under which they were conducted, and findings can vary across different trials and populations.

Evidence for Bone Density and Fracture Studies

Research explored Kombi-Kalz in populations where bone mass status was a focus, such such as those with osteoporosis. The research examined outcomes related to physical discomfort and functional capacity by focusing on measures like Bone Mineral Density (BMD) at sites such as the hip and spine, and also monitored outcomes describing episodic changes, such as the incidence of new fractures.

Trials reported measurements of BMD where numerical differences were recorded over the study period. Some trials reported patterns associated with certain measured changes in BMD. Despite these observations, the certainty remains low regarding fracture incidence across all populations, as follow-up durations were limited in many of the crucial trials. Limited information is available for how the combination was associated with functional outcomes like mobility or pain reduction, beyond the primary measurement of bone density.

What is Still Uncertain About Kombi-Kalz

Key evidence gaps include the long-term patterns of change, as long-term patterns of change are not fully established. Follow-up durations were limited in many important studies, and comparative evidence is lacking against all alternative treatments. Furthermore, findings were mixed or inconsistent across different studies, particularly when evaluating broad health outcomes. The research does not determine whether an individual will respond similarly to the group patterns observed in the trials.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Kombi-Kalz (FAQ)


Q: Is Kombi-Kalz the same as a regular calcium supplement?

Official documents describe Kombi-Kalz as a combination drug. It contains Calcium Carbonate (the mineral supplement) and Cholecalciferol (Vitamin D3). The Vitamin D3 component is included because it acts as a regulator, helping the body enhance its intestinal absorption and overall use of the calcium.


Q: What kind of benefits are generally expected from taking Kombi-Kalz?

The general therapeutic purpose, as defined in official documents, is the prevention and treatment of co-existing calcium and Vitamin D deficiencies. This action is intended to help sustain skeletal strength and support the body's overall mineral balance, known as homeostasis.


Q: How quickly does Kombi-Kalz start to have an effect?

Regulatory documents do not state a specific timeline for when a person should perceive an effect. Research supporting the product is based on changes in mineral status and bone density measured over sustained periods of daily use, which often takes several months.


Q: Can Kombi-Kalz cause weight gain?

Official safety documents list gastrointestinal effects, such as nausea, abdominal pain, and constipation, along with uncommon metabolic effects like hypercalcaemia (too much calcium in the blood). However, weight gain is not listed as a documented adverse reaction in the official product information.


Q: Is Kombi-Kalz suitable for people who are lactose intolerant?

Official labeling does not provide a general statement on lactose. However, regulatory warnings note that some dosage forms, such as chewable tablets or granules, may contain excipients (inactive ingredients) like sorbitol, sucrose, or aspartame. Patients are advised to review the specific product leaflet for complete excipient information relevant to their dietary needs.


Q: What is the difference between Kombi-Kalz and a similar drug (placeholder name)?

Kombi-Kalz is officially defined as a fixed combination product containing both elemental calcium and Vitamin D3. Regulatory documents state the combination is designed to correct concurrent deficiencies, which makes it distinct from single-ingredient therapies.


Q: Is Kombi-Kalz safe for older adults (seniors)?

Official administration guidelines confirm that adults and the elderly are the generally approved population groups for whom the supplement is intended. Eligibility is primarily determined by checking for specific contraindications related to high calcium levels or severe kidney problems.


Q: What happens if I miss a day of Kombi-Kalz?

Official regulatory guidelines typically state that if a dose is missed, it should be taken as soon as it is remembered. Regulatory guidance indicates that two doses are not to be taken at the same time to catch up. If it is almost time for the next dose, the missed dose should be skipped.


Q: Does Kombi-Kalz affect blood pressure?

Official safety documents do not state a direct effect on general blood pressure. However, they note a known interaction with Thiazide Diuretics (a class of blood pressure medicines) that requires medical monitoring due to the increased risk of mineral imbalance (hypercalcaemia).


Q: How long can a person safely take Kombi-Kalz?

Regulatory documents do not set a maximum duration for use. They state that the product is intended for sustained periods to manage chronic nutritional imbalances. Official guidelines require mandatory periodic monitoring of serum and urinary calcium levels, as well as renal function, for patients on long-term treatment.


Q: Can Kombi-Kalz be crushed or split?

The required method of intake depends entirely on the dosage form. For example, administration guidelines specify that chewable tablets must be chewed or sucked completely, not swallowed whole. The recommended approach is to adhere to the specific preparation method authorized for the form of Kombi-Kalz being used.


Q: Is Kombi-Kalz appropriate for people with certain heart conditions?

Official documents warn of a potential interaction with specific heart medicines called Cardiac Glycosides (like Digoxin). The combination increases the risk of serious rhythm disturbances (arrhythmias) due to hypercalcaemia, and medical supervision is strictly required for this pairing.


Q: Does Kombi-Kalz have interactions with common antibiotics?

Official regulatory documents specifically list interactions with certain antibiotic classes, including Tetracycline and Fluoroquinolone antibiotics. Administration must be separated from these medicines by a minimum of 2 to 4-6 hours to avoid reduced absorption of the antibiotic.


Q: How does Kombi-Kalz compare to calcium-only products?

Official scientific documents state that the Cholecalciferol (Vitamin D3) component serves as a key biological regulator. Its primary role is to actively enhance the intestinal absorption of the calcium mineral, resulting in increased overall efficiency compared to taking calcium alone.


Q: What makes Kombi-Kalz different from calcium carbonate?

Kombi-Kalz is a combination product that contains Calcium Carbonate as one of its two active ingredients. The difference is the co-formulation with Cholecalciferol (Vitamin D3), which aids in the body's proper intake and use of the calcium.


Q: Does Kombi-Kalz need to be taken every day?

The supplement is generally intended for use on a daily basis for sustained periods. This aligns with its authorized uses in managing chronic nutritional imbalances that require continuous support.


Q: Are there any long-term effects of taking Kombi-Kalz?

The primary risk noted in official documents from chronic, high-dose use is the development of Hypercalcaemia (excessive calcium in the blood). Associated complications can include the potential for renal damage and soft tissue calcification, which is why monitoring is required for long-term use.


Q: Are there any dietary restrictions when taking Kombi-Kalz?

While the product is typically taken with food for optimal absorption, official documents note that the metabolism of the Vitamin D component may be altered by the consumption of grapefruit or grapefruit juice. There are no broad restrictions on other foods mentioned in regulatory sources.


Q: Does Kombi-Kalz have any warnings about driving or operating machinery?

Official regulatory documents state that the supplement has no known influence on the ability to drive or operate machines.


Q: Are there any studies on Kombi-Kalz's use in younger adults?

Research has primarily focused on populations with the highest risk of deficiency, such as the elderly. The official labeling explicitly states that use in the paediatric population (children and adolescents) is not recommended.


Q: Is a metallic taste sometimes associated with taking Kombi-Kalz?

A 'metallic taste' is mentioned in regulatory documents as a possible symptom associated with early signs of Vitamin D intoxication due to overdose, but it is not listed as a common adverse reaction at standard doses.


Q: Are there different forms of Kombi-Kalz (like tablet, liquid, etc.)?

Yes. The product is supplied in several official dosage forms, which may include chewable tablets, film-coated tablets, and granules for oral solution. The method of administration is specific to the form being used.


Q: Does Kombi-Kalz have any known effects on mood or sleep?

Official documents do not list common side effects relating to mood or sleep at typical doses. However, signs of mental disturbances or drowsiness are noted as potential symptoms of severe hypercalcaemia, which can occur from overdose.


Q: Why might a doctor switch a patient from another product to Kombi-Kalz?

The formulation is designed to deliver both calcium and the necessary Vitamin D regulator to enhance its utilization. This specific combined approach may be used to address patients with documented co-existing deficiencies that are not adequately resolved by single-agent therapy alone.


Q: Is it possible to take too much Kombi-Kalz?

Yes. Official documents describe the risks of Overdose, which may lead to severe systemic mineral imbalance. This can result in complications like Hypercalcaemia (excess calcium in the blood), necessitating medical supervision.


Q: Does Kombi-Kalz have any known interactions with herbal supplements?

Regulatory sources address the importance of discussing all products, including herbal and nonprescription supplements, with a healthcare professional. Substances like calcium are generally documented to interfere with the absorption of other products, and this must be assessed on an individual basis.


Q: Can Kombi-Kalz cause issues with thyroid conditions?

Official documents list a specific interaction with thyroid hormone replacement therapy, such as Levothyroxine. Administration of Kombi-Kalz must be separated from these medications by at least four hours to ensure the proper absorption of the thyroid medicine.


Q: Is Kombi-Kalz only for people with low calcium levels?

Official indications confirm the product is authorized for both the prevention and treatment of concurrent calcium and Vitamin D deficiencies.


Q: Does Kombi-Kalz have a maximum length of time it can be used?

Regulatory documents do not define a maximum duration but state that long-term treatment requires mandatory periodic monitoring of serum calcium, urinary calcium, and renal function.


Q: Are there any specific foods to avoid when taking Kombi-Kalz?

While the product is generally taken with food, the metabolism of the Vitamin D component may be altered by the consumption of grapefruit or grapefruit juice, as noted in official sources. There are no broad restrictions on other foods mentioned in regulatory sources.


Q: What active ingredients are in Kombi-Kalz?

The core active ingredients, as defined in the official composition documents, are Calcium Carbonate and Cholecalciferol (Vitamin D3).

Advertisements

How should Kombi-Kalz be stored and disposed of?

How to Store and Dispose of Kombi-Kalz

The official regulatory labeling for Kombi-Kalz defines specific requirements to maintain product stability and ensure safety.

Storage Requirements

Kombi-Kalz must be stored at a temperature not exceeding 30°C. It is mandatory to keep the medicine in its original container and ensure the container is tightly closed to provide protection from both moisture and light. This adherence to packaging and environmental controls is necessary to maintain the drug's labeled shelf-life. Like all medicines, Kombi-Kalz must be kept out of the sight and reach of children.

Disposal Instructions

Any unused or expired product must be disposed of in accordance with local requirements. Regulatory guidelines typically advise against disposing of medicines via wastewater or ordinary household waste and recommend returning them to a pharmacist or designated collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Kombi-Kalz found in:

A-Z Index: